Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Idiopathic Pulmonary Fibrosis, Interstitial Lung Disease”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT05964335
What this trial is testing

Cough Reduction in IPF With Nalbuphine ER

Who this might be right for
Idiopathic Pulmonary Fibrosis
Trevi Therapeutics 165
Not applicableUnknownNCT03486262
What this trial is testing

Lung Cancer and Idiopathic Pulmonary Fibrosis : Pathological and Molecular Characterization

Who this might be right for
Lung Cancer and Idiopathic Pulmonary Fibrosis
Assistance Publique - Hôpitaux de Paris 100
Not applicableStudy completedNCT00005317
What this trial is testing

Idiopathic Pulmonary Fibrosis--Pathogenesis and Staging - SCOR in Occupational and Immunological Lung Diseases

Who this might be right for
Lung DiseasesPulmonary FibrosisLung Diseases, Interstitial+1 more
National Heart, Lung, and Blood Institute (NHLBI)
Testing effectiveness (Phase 2)Looking for participantsNCT06567717
What this trial is testing

Zinc and Nicotinamide Riboside for Idiopathic Pulmonary Fibrosis

Who this might be right for
Idiopathic Pulmonary Fibrosis
Cedars-Sinai Medical Center 60
Testing effectiveness (Phase 2)Looking for participantsNCT07652658
What this trial is testing

A Phase IIb Study to Evaluate AZD8965 in Participants With IPF.

Who this might be right for
Idiopathic Pulmonary Fibrosis (IPF)
AstraZeneca 359
Early research (Phase 1)Study completedNCT01362231
What this trial is testing

Evaluate the Safety and Efficacy of GS-6624 (Formerly AB0024) in Patients With Idiopathic Pulmonary Fibrosis

Who this might be right for
Idiopathic Pulmonary Fibrosis
Gilead Sciences 48
Not applicableLooking for participantsNCT07707245
What this trial is testing

Identification of Diagnostic and Prognostic Biomarkers in the Pathological Continuum of Bronco Chronic Obstructive Pulmonary Disease, Idiopathic Pulmonary Fibrosis and Pulmonary Neoplasia

Who this might be right for
COPDIdiopathic Pulmonary Fibrosis (IPF)Lung Cancer
Fondazione Don Carlo Gnocchi ETS 120
Not applicableStudy completedNCT05784207
What this trial is testing

An In Silico Trial to Evaluate Prospectively the Performance of a Radiomics Algorithm for UIP Compared to Medical Doctors

Who this might be right for
Idiopathic Pulmonary FibrosisInterstitial Lung DiseaseRadiomics
Maastricht University 145
Not applicableStudy completedNCT04529993
What this trial is testing

An Atlas of Airways at a Single Cell Level in Chronic Obstructive Pulmonary Disease, Idiopathic Pulmonary Fibrosis and Controls

Who this might be right for
Pulmonary Disease, Chronic ObstructiveInterstitial Pulmonary Fibrosis
Centre Hospitalier Universitaire de Nice 71
Not applicableEnded earlyNCT03477526
What this trial is testing

Status and Develepment Mental Quality of Life COPD/IPF Inpatients Before and After Pulmonary Rehabilitation

Who this might be right for
Idiopathic Pulmonary Fibrosis and COPD
Schön Klinik Berchtesgadener Land 1
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07600021
What this trial is testing

A Phase II Study to Evaluate the Efficacy and Safety of SYH2059 Tablets in Adult Patients With Idiopathic Pulmonary Fibrosis

Who this might be right for
Idiopathic Pulmonary Fibrosis
InnovStone Therapeutics Limited 156
Not applicableEnrolling By InvitationNCT04896138
What this trial is testing

University of Virginia Natural History Study

Who this might be right for
Interstitial Lung DiseaseIdiopathic Pulmonary FibrosisSarcoidosis+3 more
University of Virginia 2,500
Testing effectiveness (Phase 2)Ended earlyNCT05497284
What this trial is testing

To Assess the Efficacy of the Investigational Products Compared to Placebo in Participants With IPF

Who this might be right for
Idiopathic Pulmonary Fibrosis
Novartis Pharmaceuticals 46
Early research (Phase 1)Looking for participantsNCT07407543
What this trial is testing

Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of SRN001 in Healthy Korean and Caucasian Adult Males

Who this might be right for
Idiopathic Pulmonary Fibrosis
siRNAgen Therapeutics Inc. 30
Testing effectiveness (Phase 2)Study completedNCT02745184
What this trial is testing

Clinical Efficacy and Safety of Autologous Lung Stem Cell Transplantation in Patients With Idiopathic Pulmonary Fibrosis

Who this might be right for
Idiopathic Pulmonary Fibrosis
Shanghai East Hospital 10
Large-scale testing (Phase 3)Enrolling By InvitationNCT04905693
What this trial is testing

Extension Study of Inhaled Treprostinil in Subjects With Fibrotic Lung Disease

Who this might be right for
Idiopathic Pulmonary FibrosisInterstitial Lung DiseaseProgressive Pulmonary Fibrosis
United Therapeutics 1,850
Early research (Phase 1)Study completedNCT05473533
What this trial is testing

Study of Single and Multiple Doses of PRS-220 Administered by Oral Inhalation in Healthy Subjects

Who this might be right for
Healthy
Pieris Australia Pty Ltd 64
Testing effectiveness (Phase 2)Study completedNCT04419506
What this trial is testing

Test How Taking BI 1015550 for 12 Weeks Affects Lung Function in People With Idiopathic Pulmonary Fibrosis (IPF)

Who this might be right for
Idiopathic Pulmonary Fibrosis
Boehringer Ingelheim 147
Not applicableEnded earlyNCT03562247
What this trial is testing

Telenursing and Remote Monitoring in Idiopathic Pulmonary Fibrosis (IPF)

Who this might be right for
Idiopathic Pulmonary Fibrosis
Vanderbilt University Medical Center 31
Not applicableWithdrawnNCT04494334
What this trial is testing

Development of Airway Absorption Sampling Methods

Who this might be right for
Idiopathic Pulmonary FibrosisSarcoidosis
Imperial College London
Next Page